Strategy price target lowered to $175 from $220 at Monness Crespi

TipRanks

Wed, Apr 9, 2025, 7:56 AM 1 min read

Monness Crespi lowered the firm’s price target on Strategy (MSTR) to $175 from $220 and keeps a Sell rating on the shares. The stock’s “lowered premium to HODL” reflects a closing window for the equity and fixed income capital raise plan, says the analyst, who believes it is “appropriate to lean into this bet” as the window for capital raises is seemingly closing on the fixed income side, in particular, creating a need to rely upon equity dilution at an “increasingly disproportionate clip.”

Stay Ahead of the Market:

Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on MSTR:

Disclaimer & Disclosure Report an Issue